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Abstract
Background: Patient empowerment represents a potent tool for addressing racial, ethnic and socioeconomic
disparities in health care, particularly for chronic conditions such as HIV infection that require active patient
engagement. This multimodal intervention, developed in concert with HIV patients and clinicians, aims to provide
HIV patients with the knowledge, skills, attitudes and tools to become more activated patients.
Methods/Design: Randomized controlled trial of a multimodal intervention designed to activate persons living
with HIV. The intervention includes four components: 1) use of a web-enabled hand-held device (Apple iPod
Touch) loaded with a Personal Health Record (ePHR) customized for HIV patients; 2) six 90-minute group-based
training sessions in use of the device, internet and the ePHR; 3) a pre-visit coaching session; and 4) clinician
education regarding how they can support activated patients. Outcome measures include pre- post changes in
patient activation measure score (primary outcome), eHealth literacy, patient involvement in decision-making and
care, medication adherence, preventive care, and HIV Viral Load.
Discussion: We hypothesize that participants receiving the intervention will show greater improvement in
empowerment and the intervention will reduce disparities in study outcomes. Disparities in these measures will be
smaller than those in the usual care group. Findings have implications for activating persons living with HIV and for
other marginalized groups living with chronic illness.
Trial registration: ClinicalTrials.gov Identifier: NCT02165735, 6/13/2014.
Keywords: Patient activation, HIV, Health information technology
Background
There are large, potentially avoidable differences in the in-
cidence, prevalence and outcomes of HIV infection [1].
Combination antiretroviral therapy (cART) represents a
powerful treatment with the potential to dramatically re-
duce disparities in morbidity and mortality from HIV.
cART has radically altered the course of HIV and trans-
formed it into a chronic disease with a life expectancy
similar to adult onset diabetes [2]. Successful management
of HIV-infection requires patients to be empowered, (i.e.
engaged, informed, collaborative, committed, and tolerant
of uncertainty). HIV disease control requires highly indi-
vidualized cART based on consideration of multiple fac-
tors. These include viral genotype, short and long-term
side effects and toxicity, dosing frequency, pill burden, po-
tential drug-drug interactions, comorbidities, and most
importantly, consideration of patient preferences and
values [3]. Viral suppression, (i.e. attainment of un-
detectable viral loads), requires long-term rates of medi-
cation adherence that exceed 95 % [4]. Effective clinical
management requires near complete suppression of
viral replication in order to restore immune function,
minimize viral mutations and drug resistance, prevent
opportunistic infections, and decrease risk of transmis-
sion of HIV infection to others [4].
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Poor and minority patients are less likely to be active
partners in their own care [5]. Poor and minority patients,
including persons living with HIV (PLWH), report lower
partnership levels with their clinicians, [6] miss more
office visits, [7] ask fewer questions during their visits,
[8–10] report less confidence in self-management,[11]
and more frequently miss doses [12] or stop taking their
cART [13]. Groups that have been historically disem-
powered also have lower knowledge of their medica-
tions, [14] are less likely to report benefits from cancer
screening, [14] and less likely to report involvement in
cancer screening decisions [15].
Our intervention, developed and piloted in collab-
oration with PLWH, clinicians in Federally Qualified
Health Centers (FQHCs); Patient-Centered Medical
Home and a primary care practice-based research
network (PBRN), will address these disparities by fo-
cusing on empowerment and information access that
are needed to make decisions that reflect patients’
values.
Study aims and hypotheses
The overarching aim of this project is to assess the im-
pact of a multi-model eHealth group behavioral inter-
vention on patient activation among persons living with




We will conduct a parallel randomized controlled trial. This
design allows us to examine pre- and post-assessments of
participants randomized to the intervention (treatment
group) compared to participants randomized to usual care
(control group). Given our focus on individual patients, the
nature of our intervention, including its reliance on training
and specific tools, the risk for contamination between par-
ticipants will be relatively small. Any such contamination
will bias results towards the null. We considered other de-
signs including randomizing by practice site (cluster RCT),
stepped wedge and staggered enrollment trials, but did not
choose these designs due to few clusters, data collection
burden, and relatively short funding time frame (3 years).
Eligibility
To maximize generalizability, we opted for a pragmatic
trial that employs broad inclusion criteria of participants.
Inclusion criteria
>18 years, confirmed HIV diagnosis, and receiving care
within a participating site.
Exclusion criteria
Inability to provide informed consent, inability to read
and speak English.
Participant recruitment and enrollment
Patients will be recruited from four participating sites in
Rochester NY and from four sites in the New York
Metropolitan Area. Most of the Rochester sites are dedi-
cated HIV practices that also provide primary care to
some of their patients, while all of the NYC sites are
Federally Qualified Health Centers (FHQC) that provide
primary care, including HIV care. Clinicians and staff in
participating sites will refer interested HIV+ patients to
a study research assistant (RA). The RA will meet in a
private area and review the study protocol and consent
patients.
Procedures for randomization and allocation
Sequential identification (ID) numbers will be generated
by our study biostatistician using computer generated
random numbers stratified by site (Rochester or NYC)
to minimize potential site variation between groups. As-
signments will be concealed in sealed opaque, envelopes
that contain the group assignment. Following confirm-
ation of the participant’s eligibility, informed consent,
and completion of the baseline assessment (T0), the RA
will open the envelope and notify the participant
whether they have been assigned to the intervention or
usual care group.
Procedures and timing of data collection
The RA will administer surveys to all participants at
three times: T0 (baseline); T1 (8–10 weeks following
randomization), and T2, (1–3 days following the
Table 1 Study Aims and Hypotheses
Aim 1: Improve PLWH’s empowerment
H 1.1: We will improve patient activation; decision making ability; and
perceived knowledge, comfort, and perceived skills at finding,
evaluating, and applying electronic health information to health
problems.
H 1.2: We will improve clinicians’ communication skills as perceived
by PLWH.
Aim 2: Increase PLWH’s receipt of evidence-based care
H 2.1: We will improve patient confidence in adhering to combination
antiretroviral treatment (cART), self-reported adherence to cART, and
HIV viral suppression (undetectable viral load).
H 2.2: We will increase receipt of evidence-based clinical preventive
services.
Aim 3: Improve PLWH’s health
H 3.1: We will improve mental, social, and overall health
Aim 4: Reduce disparities in PLWH’s empowerment
H 4.1: We will produce the greatest improvement in activation for
those with lowest baseline activation.
H 4.2: We will observe comparable improvements by race, ethnicity,
and education.
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patients’ next HIV visit which is using 14–24 weeks after
baseline). We have chosen to link the timing of the T2
survey to patients’ HIV visits in order to ensure reliable
patient recall of the visit. Most patients have HIV visits
every 3–4 months, and their HIV Viral Load is routinely
measured at these visits. T3 (>52 weeks following
randomization) involves chart abstraction. RAs or par-
ticipating clinical site staff trained in chart abstraction,
who are blinded to treatment allocation, will abstract the
data from the EHR. Fidelity checks will be conducted on
10 % of the sample by an RA and/or study coordinator
in order to achieve >90 % agreement.
Data management and quality control
An RA will enter data into a laptop computer and up-
load it into the Web-based RedCap database [16]. In-
valid responses and outliers (those falling outside of
response ranges) will be corrected immediately. Quality
reports will be conducted weekly using RedCap analytic
tools to assess missing data and rates of invalid re-
sponses. All laptops will be fully encrypted and password
protected. Files linking participant names with study ID
numbers will be stored separately on a secure, password
protected server.
Group facilitator training and fidelity
We have conducted group training of group facilitators
for the intervention from Rochester and NYC using com-
bined in-person and webcasts/video tele-conferences. The
training focused on key knowledge, skill, and attitudes
(KSAs) for trainees to facilitate groups and also provide
individual coaching. These KSAs include knowledge of
curriculum content including use of the device and ePHR,
skills in facilitating adult learning in groups, and enthusi-
asm and expectation that every learner will succeed. The
facilitator training was based on application of the steps
specified in the training manual. We used direct observa-
tion and video recording to review key skills and practice
until the specified behavior could be performed with high
fidelity. During the intervention phase, the facilitators will
also meet monthly and use fidelity rating check lists to en-
sure adherence. A national expert in fidelity rating will as-
sist with fidelity training, refinement of the fidelity
checklist, and analyses of protocol adherence during train-
ing sessions.
Intervention
The intervention primarily focuses on patient activation.
It includes group sessions to teach participants how to
use the hand-held device, how to use the electronic pa-
tient health record (ePHR), and how to effectively com-
municate with the patients’ HIV clinician.
Group training
Group training, co-learning and sharing is critical to facili-
tating patient empowerment. While an iPod represents “a
hook” to encourage participants to enroll, we explicitly
target key intrinsic motivational factors (autonomy, com-
petence, and relatedness) as a means for energizing motiv-
ation to learn to use and apply empowerment tools and
skills, and to encourage attendance, participation (dose)
and retention (maintenance) in the intervention. Each of
the six 90-min sessions focuses on development of a basic
competency within a context that supports patient auton-
omy, competence and human relationships. Content is in-
tegrated (i.e. role playing is mixed with app downloading)
to maintain enthusiasm. A training manual appears in the
Appendix. Key tasks are summarized below: (Table 2).
Hand-held device
For the hand-held device, we selected the Apple iPod
Touch® based on its widespread availability and adoption,
versatility (number of applications, web-enabled), intuitive
interface/usability, relative low cost, no requirement for
phone or internet service provider contracts, and its “cool-
ness” factor. The latter is important to promoting initial
patient engagement, including new membership in the
technology community. This helps improve patients’ inclu-
sion in mainstream society which has greater levels of
web-access (both cellular and ISP-based).
ePHR
We will load each device with our customized ePHR devel-
oped for PLWH named URHealth. URHealth possesses the
following features. 1) Drop down menus for common HIV
medications with accompanying pill pictures; 2) Common
lab tests with brief, understandable explanations. 3) Ability
to set reminders for appointments and medications. 4) Per-
sonalized “Prompt list” of potential questions for patient to
ask their clinician. These are generated based on patient’s
age, date of birth and data the patients enter into their de-
vice. For example, if the person is under 26 years old, they
will be prompted to ask about the HPV vaccine (unless they
have entered dates of receipt). Prompts can be personalized
by prioritizing them. They can be augmented using
Table 2 Key tasks for group training
• Project overview, value affirmation exercise, and basic use of the
device (e.g. turning on and off, password, settings, etc.)
• Basic training in use of ePHR (recap and introduction to features,
password, back-up, and importing contacts).
• Advanced training in use of ePHR (reminders, data entry, confirmation
of data, To Ask list).
• Communication and use of web sites (training in formulating,
prioritizing, asking questions, and bookmarking high quality web sites).
• Communication and health apps (role play challenging situations,
using ePHR during visit, and downloading health relevant apps).
Fiscella et al. BMC Public Health  (2015) 15:1056 Page 3 of 9
personally relevant questions that participants will be
trained to generate for themselves. The app is password-
protected, adding an additional layer of security over the
iPod itself.
Pre-visit coaching
After participants in the intervention group have com-
pleted their last session, the RA will meet with the pa-
tient prior to their next office visit with their HIV
provider. This one-time individual coaching session is
designed to reinforce application of skills learned during
the group training. A separate manual and fidelity
checklist has been developed for this one-on-one ses-
sion. Key tasks for the session are summarized below
(Table 3).
Clinician training
We will train clinicians to engage patients in the interven-
tion group, (i.e. those who present with their ePHR in the
visits) through an educational “lunch and learn” session
that is CME-accredited. These educational sessions will
address the purpose of the project and basic clinician be-
haviors to facilitate empowerment. Drs. Carroll and
Fiscella will lead these sessions. We will use training
approaches used in previous studies [17–19] that are sup-
ported by systematic reviews of randomized controlled tri-
als of clinician training [20, 21]. We include explicit
demonstrations using brief videos [22]. We will show ex-
amples of effective and ineffective communication. These
include encouraging the patient to use their ePHR for
questions, praising patients for engagement, helping pa-
tients prioritize their questions, and providing patients
with relevant information to enter into their ePHR.
Clinicians will be encouraged to download URHealth
onto their own personal devices, in order to familiarize
themselves with the ePHR and to enable them to pro-
vide ongoing support and effective answers to ques-
tions from their patients about use of the ePHR.
Training manual
We have developed a detailed training manual for in-
struction of project staff and peers as facilitators to con-
duct the patient group sessions. The onsite train-the-
trainers sessions will focus on competency in conducting
each of the six group sessions with specific attention to
displaying enthusiasm, active engagement of group
through questions and sharing, staying on task and time,
and ensuring all members are able to rehearse particular
skill during the session. We will assess fidelity using an
observation checklist applied to intervention group vid-
eotapes. All train-the-trainer sessions will be recorded to
train new staff as well as provide refresher training if drift
occurs. After study completion, these trainings will be
posted online to enhance dissemination and sustainability.
Usual care
Participants assigned to this group will receive usual care
from their HIV clinician during the duration of the
study. They will receive the same surveys at the same
time periods, T01–T3 as those assigned to the interven-
tion group. Following the completion of their final as-
sessment (T3), participants in the usual care group will
receive the iPod loaded with the URHealth application,
and will be provided with the training manual to assist
with self-teaching on the use of the application.
Study outcomes and measures
Our study measures reflect our patients’ choice of out-
comes related to empowerment including activation,
eHealth literacy, and greater decision-making and in-
volvement in care. These outcomes will be assessed
using validated scales with sound psychometric proper-
ties and through chart abstraction data. These are sum-
marized below (Table 4).
Patient empowerment
Our primary outcome is patient empowerment assessed
using the Patient Activation Measure (PAM). We will cap-
ture related additional dimensions of empowerment in-
cluding eHealth literacy (eHealth Literacy Scale eHEALS
[23, 24]), patient involvement in their care (Patient In-
volvement in Care [25]) and, patient confidence in their
health care decision making (Decision Making Self
Efficacy Scale [26]).
Patient health status
We assess patient’s mental, social and overall health
based on the well-validated Medical Outcomes Study
SF–12 [27]. It provides an overall score and relevant
subdomain scores.
Adherence measures
We will assess adherence and receipt of evidence-based
care using a series of adherence related measures and
data abstracted from the EHR. These include validated
measures of adherence to cART [28] and patient self-
efficacy related to adherence, [29] in addition to viral
load values (from medical records) and a summary index
of evidenced-based care (from medical records). The
index will be derived based on receipt of the number of
Table 3 Key tasks for pre-visit coaching
• Bring iPod/ePHR (reminding the patients to bring their iPod to their
patient coaching session and to their subsequent doctor visit).
• Preparation of questions (ensuring that the patient has identified and
recorded in their iPod key questions to ask their clinician).
• Application and rehearsal of skills (coaching the patient through role
play asking his/her questions.
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evidence-based measures received divided by the total
number the patient is eligible for. These include those
receiving an A or B rating by the US Preventive Services
Task Force, e.g. breast, cervical and colorectal cancer
screening, immunizations, lipid screening,
Patient social disadvantages
We will assess race (White, Black, Asian, Other) and
ethnicity (Latino or not), age, and sex based on self-
report. We define low education as absence of any high
school degree. Low activation and low eHealth literacy
will be based on less than the median value on the PAM
and eHEALS.
Clinician communication
We will assess the communication skills of clinicians using
the Doctor-Patient Communication Skills instrument [30].
This validated scale assesses key aspects of clinician com-
munication from the perspective of the patient. We will
minimize patient reporting bias by aggregating clinician
scores across patients. We chose to use patient ratings of
clinicians rather than observer ratings because these are
more patient-centered measures and patients’ perceptions
probably have the greatest impact on patients’ behavior; as
well as their lower costs and greater capacity for pragmatic
implementation. We chose this scale over other patient
reported measures of clinician communication because it
comes closest to measuring the clinician competencies
that we address in our clinician training and which our
patients tell us are most meaningful to them.
Preliminary data
We piloted the intervention with 32 PLWH.
We obtained pre and post assessments on the partici-
pants and assessed change scores. Our pilot data below
(Table 5) show improvement in key measures. In
addition, participants with the least education, activa-
tion, and least eHealth literacy benefited the most. Spe-
cifically, those with less than a high school education
and those with lower activation or lower eHealth literacy
(i.e. below the median for the group) showed larger im-
provements in adherence, eHealth literacy, perceived in-
volvement in care, decision in self-efficacy, and patient
activation than those with higher levels.
Planned analysis
Following collection and cleaning of data (T0–T3), the
underlying assumptions of all analyses will be checked
using appropriate graphical and numerical methods [31].
Data accuracy will be investigated upon discovery of any
Table 4 Study measures, data source, and timing
Construct (Hypothesis) Measure Data type source Collection points
Participant characteristics
Demographics Standardized questions Survey T0
Computer experience Standardized questions Survey T0
Health history Standardized questions Survey T0
Aim 1 (Empowerment)
Patient activation (H1.1) PAM [56, 57] Scale T0, T1, T2
Decision making (H1.1) Decision Self Efficacy Scale [26] Scale T0, T1, T2
eHealth Literacy (H1.1) eHEALS [23, 24] Scale T0, T1, T2
Involvement in Care (H1.2) Perceived Involvement in Care [25] Scale T0, T1, T2
Aim 2 (Evidence-based care)
HIV adherence self-efficacy (H2.1) ASES [29] Survey T0, T1, T2
Adherence to cART (H2.1) Past week adherence [28] Survey T0, T1, T2
HIV viral load <50 (H2.2) HIV viral loads (both actual level; and whether
undetectable or not)
Chart abstraction T0, T2
Evidenced based preventive care Cancer screening/immunizations [58] Chart abstraction T0, T3
Aim 3 (Health)
Physical and Mental health/Quality of Life (H3.1) SF-12 [27] Scale T0, T1, T2
Aim 4 (Moderators)
Low Activation (H4.1) PAM and eHEALS (<median) Scales T0
Minority race/ethnicity (H4.2) Standardized questions Survey T0
Low education (4.2) Standardized questions Survey T0
Clinician patient centeredness Instrument on Doctor-Patient Communication Skills. [30] Scale
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outliers or influential data points. If an outlier is de-
tected, we will truncate the outlier by assigning a reason-
able value or replacing it using the adjacent values from
the remaining data. We will try to utilize all data points
in the final analysis.
The proposed study adopts a randomized repeated
measures pre-test/post-test design and our analytic plan
reflects this design. We will use generalized estimating
equations (GEE) to obtain robust estimates and to ac-
count for the repeated measures study design and the
correlated data structure of subjects nested within study
site [32]. The chosen link function for the models will be
appropriate for the distribution of each outcome. Unless
otherwise stated, all statistical tests will be performed at
the two-tailed 5 % level of significance. Likewise, 95 %
confidence intervals will be constructed for estimation
of effects (e.g., difference in outcomes between interven-
tion and control groups). We will use Dunnett and Hsu’s
methods to control for multiple comparisons in secondary
outcomes [33]. All analyses will be performed with SAS®
statistical software version 9.3 (SAS Institute, Cary NC).
We will summarize frequencies of categorical variables
and means or medians for continuous and ordinal vari-
ables. Continuous variables with skewed distributions
will be transformed to approximate normality. We will
construct tables that display baseline characteristics for
participants, overall and by (blinded) group assignment.
We will compare baseline information on participants
including demographic characteristics, previous com-
puter use, and health factors. We will assess whether at-
trition differs across baseline characteristics or by group
assignment and adjust for differences if present using
multiple imputation if necessary. We will conduct
intention-to-treat analyses.
Every effort will be made to facilitate and encourage
participants’ completion of all surveys. In the event that
missing data occur, we will attempt to contact partici-
pants and obtain the data or to find out why the surveys
or items are missing. The reasons for missing data will
be documented and the mechanism for missing data will
be examined [34]. If needed, data will be imputed and a
weighted generalized estimating equations (WGEE)
model will be applied using the inverse probability of
missingness as the sample weight [35]. Sensitivity ana-
lyses will be performed to determine the impact of key
assumptions.
Aim 1: Improve PLWH’s empowerment
To assess H 1.1 (Improvement in patient activation; de-
cision making ability; and perceived knowledge, comfort,
and perceived skills at finding, evaluating, and applying
electronic health information to health problems), we
will compare changes in patient activation (primary out-
come), eHealth literacy, and decisional self-efficacy out-
comes by assigned randomization group using GEE
models that control for baseline scores. All models will
be adjusted for any potential confounders identified by
the initial analyses. We will use the same approach to as-
sess H 1.2 (substituting Perceived Involvement in Care).
Aim 2: Increase PLWH’s receipt of evidence-based care
To assess H 2.1 (improvement in patient improve pa-
tient confidence in adhering to combination antiretro-
viral treatment (cART), self-reported adherence to
cART, and HIV viral suppression), we will substitute
these dependent variables in the above models. Similarly
for H 2.2 (improvement in evidence-based care), we will
index for evidence-based care for the dependent vari-
able. This index will be created by passed on ratio of in-
terventions that the patient received versus the number
they were eligible for.
Aim 3: Improve PLWH’s health
To assess H 3.1 (improvement in mental, social and
overall health) we will use the same approach substitut-
ing the scores from the SF-12 physical and mental health
components.
Table 5 Characteristics of PLWH in pilot study (n = 32)
Age mean (Standard deviation) 49 (10.2)
Gendera
Female 16 (50 %)
Male 15 (47 %)
Race/ethnicity
Hispanic 8 (25 %)
Non-Hispanic White 1 (3 %)
Non-Hispanic Black 20 (63 %)
Other 3 (6 %)
Computer Use (% none) 7 (22 %)
Insurance Type
Public (Medicaid/Medicare) 30 (94 %)
Private 0 (0 %)
ADAP 4 (6 %)
Education
<High school 10 (31 %)
High school diploma or GED 6 (19 %)
More than high school 16 (50 %)
Annual Incomea
<$20,000 29 (91 %)
$20,000–29,999 2 (6 %)
≥$30,000 0 (0 %)
aNote not all categories total 100 % due to missing values
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Aim 4: Reduce disparities in PLWH’s empowerment
To assess H 4.1 (greatest improvement in patient activa-
tion will be seen in those with lowest baseline activation
scores), we will enter interaction terms into the models
with treatment assignment. The interaction terms will be
based on median cut-offs for activation. To assess H 4.2.
(comparable improvements in by race, ethnicity and edu-
cation). We repeat the above process using an interaction
term between treatment assignment and the sociodemo-
graphic characteristics.
Power
The number of participants included in the intervention
group and the usual care groups is based upon a series
of power analyses. For H 1.1 – H 3.1, we estimated de-
tectable difference using the method described by Donner
and Klar, [36] using 8 study sites total, a significance level
of 0.05, and a minimum power of 80 %. The intra-cluster
correlation (ICC = 0.0207) was estimated from our pilot
data and is consistent with other studies [37]. We plan to
enroll 360 participants to allow for attrition and assume a
15 % drop-out rate. Thus, we will be able to detect an ef-
fect size of 0.51 for each of the measures in Table 6. For
H 4.1 and H 4.2, we ran Monte Carlo simulations to de-
termine that we will have a minimum of 80 % power for
the interactions [38].
Funding support, trial registration, ethics approval
This trial is exclusively funded by PCORI. The trial is reg-
istered at ClinicalTrials.gov (NCT02165735). Ethical ap-
proval was obtained from the Institutional Review Boards
of University of Rochester and Clinical Directors Network
(CDN) and Lutheran Family Health Center Network IRB.
Discussion
Poor and minority patients including PLWH report lower
engagement in their care, [6] miss more office visits, [7]
ask fewer questions during their visits, [8–10] report less
confidence in self-management, [11] and more frequently
miss doses [12] or stop taking their cART [13]. Groups
that have been historically disempowered also have lower
knowledge of their medications. [14] These disparities likely
contribute to disparities in adherence, [39, 40] viral
suppression, [41, 42] and ultimately - to disparities in HIV
treatment outcomes, [43–45] including hospitalizations and
mortality [2, 46].
These disparities in engagement may be further exac-
erbated by the well-documented digital divide. Federal
meaningful use standards are driving adoption of online
PHRs for patients [47]. Lower use of these online portals
by lower income and minority patients, [48–55] could
further exacerbate current disparities in patient engage-
ment by creating digital barriers to access to test results,
requests for refills and appointments, and electronic
messaging with clinicians.
This intervention is among the first to explicitly target
these disparities among PLWH using a unique training
program that focuses on self-management using a hand
held PHR. Unique features include an explicit focus on
use of peer-trainers, participant-to-participant teaching
and sharing about HIV self-management and health
technology, use of a customized PHR for PLWH, and
explicit training in communication with clinicians linked
to use of the PHR.
Perhaps most notably, the design of the intervention
and study emerged using a community-based partici-
patory research model involving collaboration between
PLWH, clinicians and HIV organizations. This active
partnership has ensured that all aspects of the inter-
vention are tailored to the needs of PLWH, including
those with low eHealth literacy and that measures
capture key outcomes meaningful to patients, particu-
larly empowerment, which we have operationalized
using the patient activation measure. The study design
helps ensure rigorous evaluation of the intervention in-
cluding benefit to those with lower levels of activation and
eHealth literacy.
The primary limitation is that it will not be possible to
determine for certain which element of this multimodal
intervention improves outcomes the most. However,
proposed mediational analyses may shed some light on
particular salient pathways. If shown to be effective, this
study will provide an intervention that can be general-
ized to support self-management for other chronic dis-
eases, and which can be disseminated, scaled up and
sustained over time.















HIV adherence self-efficacy 0.15 −0.64 −0.19 0.18 −0.38 −0.02 −0.05
eHealth literacy 0.85 0.35 0.61 0.98 0.18 0.94 0.35
Perceived Involvement in Care 0.57 0.37 0.24 0.61 0.11 0.48 0.26
Decision self-efficacy 0.81 0.23 0.34 0.86 0.16 0.48 0.52
Patient Activation 0.50 −0.85 0.24 0.52 −0.155 0.32 0.11
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